Sunday, April 12, 2026 | 06:27 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 764 - Coronavirus Vaccine

42 failed airlines and counting: Wait for vaccine crushes industry

A new wave of Covid-19 lockdowns combined with the usual winter slump in traffic will push more airlines toward the brink, says one analyst.

42 failed airlines and counting: Wait for vaccine crushes industry
Updated On : 23 Nov 2020 | 8:54 PM IST

UK regulator begins reviewing Pfizer-BioNTech coronavirus vaccine data

The UK is expected to receive a total of 40 million doses by the end of 2021, enough to vaccinate up to a third of the population, with the majority of doses anticipated in the first half of next year

UK regulator begins reviewing Pfizer-BioNTech coronavirus vaccine data
Updated On : 23 Nov 2020 | 8:34 PM IST

Astra-Oxford Covid-19 vaccine works but doses could be in short supply

Pfizer and Moderna may have an initial advantage in dealing with manufacturing challenges, as their novel messenger RNA technology can be scaled up.

Astra-Oxford Covid-19 vaccine works but doses could be in short supply
Updated On : 23 Nov 2020 | 8:09 PM IST

LIVE: UP restricts visitors to indoor events at 100 as Covid-19 tally rises

Coronavirus live updates: At 1,780,208, Maharashtra has the highest number of coronavirus cases, followed by Karnataka 873,046, Andhra Pradesh 862,000, Tamil Nadu 769,000 and Kerala 562,735

LIVE: UP restricts visitors to indoor events at 100 as Covid-19 tally rises
Updated On : 23 Nov 2020 | 8:00 PM IST

Top headlines: RBI panel under fire, AstraZeneca says Covid shot successful

A vaccine developed by AstraZeneca and the University of Oxford prevented 70% of people from developing the coronavirus in late-stage trials, and more top headlines of the day

Top headlines: RBI panel under fire, AstraZeneca says Covid shot successful
Updated On : 23 Nov 2020 | 4:45 PM IST

Vaccine highly effective in preventing Covid-19, says AstraZeneca

AstraZeneca says late-stage trials of its Covid-19 vaccine were highly effective'' in preventing disease.

Vaccine highly effective in preventing Covid-19, says AstraZeneca
Updated On : 23 Nov 2020 | 4:35 PM IST

AstraZeneca will have enough Covid-19 vaccine for 200 mn doses this year

The company plans to keep the "active" drug substance in stock while it awaited regulatory approval around the world

AstraZeneca will have enough Covid-19 vaccine for 200 mn doses this year
Updated On : 23 Nov 2020 | 4:32 PM IST

First Americans could be vaccinated next month: House vaccine chief

An FDA vaccine advisory committee is slated to meet December on 10

First Americans could be vaccinated next month: House vaccine chief
Updated On : 23 Nov 2020 | 4:07 PM IST

Covid-19 Factoid: Rajasthan fights surge, gets over 3,000 cases for 2 days

India had been witnessing more recoveries as compared to daily new case additions resulting in a drop in active cases count.

Covid-19 Factoid: Rajasthan fights surge, gets over 3,000 cases for 2 days
Updated On : 23 Nov 2020 | 2:46 PM IST

India Coronavirus Dispatch: Investors shelve start-up plans this year

Wealthy nations won't waive IPR rules for Covid drugs, Why Covid spikes in some places, study says reinfection unlikely for six months at least-news on how the country is coping with the pandemic

India Coronavirus Dispatch: Investors shelve start-up plans this year
Updated On : 23 Nov 2020 | 2:41 PM IST

World Coronavirus Dispatch: The stay-at-home economy is here to stay

South Korea toughens social distancing norms, Europe plans cautious easing of lockdown, UK starts trials for antibody cocktail, and other pandemic-related news across the globe

World Coronavirus Dispatch: The stay-at-home economy is here to stay
Updated On : 23 Nov 2020 | 2:09 PM IST

India still doesn't know why Covid affected whom it did and how it did that

There is a wide variation in the spread of COVID-19 between states. Areas with higher population density are expected to have more cases, but varying testing rates could be affecting case detection

India still doesn't know why Covid affected whom it did and how it did that
Updated On : 23 Nov 2020 | 1:13 PM IST

New coronavirus cases stay below 50,000 in India for 16th day straight

With 44,059 new cases of Covid-19 infections, India's tally mounted to 91,39,865 on Monday

New coronavirus cases stay below 50,000 in India for 16th day straight
Updated On : 23 Nov 2020 | 11:45 AM IST

Frequent, rapid testing can cripple coronavirus within weeks: Study

Testing half the population weekly with inexpensive, rapid-turnaround Covid-19 tests would drive the virus toward elimination within weeks, claim researchers

Image
Updated On : 23 Nov 2020 | 11:07 AM IST

Global coronavirus update: Cases top 58.5 million, says Johns Hopkins

The overall number of global coronavirus cases has topped 58.5 million, while the deaths have surged to more than 1.38 million, according to the Johns Hopkins University

Global coronavirus update: Cases top 58.5 million, says Johns Hopkins
Updated On : 23 Nov 2020 | 10:08 AM IST

Top headlines: India may get 1st vaccine by Feb, FMCGs expand rural reach

India is likely to issue an emergency use authorisation to at least one Covid vaccine by the end of January and health workers will be the first to be inoculated. More headlines in our evening roundup

Top headlines: India may get 1st vaccine by Feb, FMCGs expand rural reach
Updated On : 23 Nov 2020 | 7:42 AM IST

G20 leaders vow to help poorest countries in the post-Covid world

Discuss efforts to ensure fair distribution of a coronavirus vaccine globally

G20 leaders vow to help poorest countries in the post-Covid world
Updated On : 23 Nov 2020 | 1:40 AM IST

Moderna to charge govts $25-$37 for Covid-19 vaccine: CEO tells paper

Moderna has said its experimental vaccine is 94.5% effective in preventing Covid-19, based on interim data from a late-stage clinical trial.

Moderna to charge govts $25-$37 for Covid-19 vaccine: CEO tells paper
Updated On : 23 Nov 2020 | 1:35 AM IST

If all goes well, India may get first Covid-19 vaccine by February

AstraZeneca vaccine is likely to cost Rs 500-600 per dose in the private market

If all goes well, India may get first Covid-19 vaccine by February
Updated On : 23 Nov 2020 | 6:10 AM IST

Govt plans air freight stations to transport coronavirus vaccines

Air freight stations near manufacturing sites will enable direct movement of vaccines to the aircraft

Govt plans air freight stations to transport coronavirus vaccines
Updated On : 23 Nov 2020 | 6:10 AM IST